2018
DOI: 10.1016/j.biopha.2018.08.161
|View full text |Cite
|
Sign up to set email alerts
|

Differentially expressed circular RNAs in systemic lupus erythematosus and their clinical significance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
31
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(32 citation statements)
references
References 40 publications
1
31
0
Order By: Relevance
“…They could competitively bind to the miRNA and then decrease the inhibitory effect of the miRNA on the expression of target genes 23, 24. Many studies have proved that circRNAs are potential biomarkers and participate in pathogenesis of various autoimmune diseases 25, 26, 27. For instance, decreased hsa_circ_0044235 in PBMCs has been confirmed to have significant value in the diagnosis of RA.…”
Section: Discussionmentioning
confidence: 99%
“…They could competitively bind to the miRNA and then decrease the inhibitory effect of the miRNA on the expression of target genes 23, 24. Many studies have proved that circRNAs are potential biomarkers and participate in pathogenesis of various autoimmune diseases 25, 26, 27. For instance, decreased hsa_circ_0044235 in PBMCs has been confirmed to have significant value in the diagnosis of RA.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it was speculated that the dE circRNAs or miRNAs associated with blood loss could also be correlated with ONFH. Third, the dE circRNAs and miRNAs might also result from the autoimmune diseases such as SLE instead of ONFH, which has been demonstrated in previous studies (44)(45)(46). It is true that SLE itself could lead to DE miRNAs and circRNAs.…”
Section: Discussionmentioning
confidence: 75%
“…These properties indicate that the potential of circRNAs to be ideal biomarkers for human diseases (21). Moreover, the diagnostic performance of plasma or PBMC circRNA has been examined in SLE (38,39). However, to the best of our knowledge, the expression profiles and diagnostic performance of circulating circRNAs in peripheral blood from patients with SLE have been rarely reported, and there was previously only one paper investigating circRNAs expression in peripheral blood from patients with SLE (40).…”
Section: Discussionmentioning
confidence: 99%